Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia
GHDx Entry last modified on: Jan 31, 2024
COVID-19
Dataset Records for COVID-19
Displaying 201 - 250 of 1564
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
GHDx Entry last modified on: Apr 10, 2023
Three-month Clinical Status of A Cohort of Adult Hospitalized COVID-19 Pimpaka Srisiriwanna M.D., Poolsuk Janepanish Visudtibhan Ph.D., Kumthorn Malathum M.D
GHDx Entry last modified on: Mar 22, 2024
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
GHDx Entry last modified on: Mar 22, 2024
India COVID-19 Crowdsourced Patient Database: Vaccine Doses Administered by State
GHDx Entry last modified on: Nov 15, 2022
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021
RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021
Epi surveillance:
Subnationally representative
Eswatini COVID-19 Rapid Gender Assessment Survey 2021
Survey:
Cross-sectional - Individual - Interview
Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study)
GHDx Entry last modified on: Jan 31, 2024
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2020-2021 - Round 2
GHDx Entry last modified on: Aug 4, 2023
Covid-19 Vaccination Strategy In Spain 2020-2022
Estrategia De Vacunación Covid-19 En Espana
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
COVID-19 Vaccination and Case Trends by Age Group, United States 2020-2022
Archive: COVID-19 Vaccination and Case Trends by Age Group, United States
Administrative data:
Epi surveillance
Unemployment Insurance (UI) Benefits: Permanent-Law Programs and the COVID-19 Pandemic Response
Report:
Financial - Nationally representative
Italy Open Data on COVID-19 Vaccines 2020-2022
covid19-opendata-vaccini, Open Data su consegna e somministrazione dei vaccini anti COVID-19 in Italia
United States - COVID-19 Reported Patient Impact and Hospital Capacity by State Timeseries 2020-2022
Epi surveillance:
Health facility - Subnationally representative
United States - COVID-19 Reported Patient Impact and Hospital Capacity by Facility 2020-2022
COVID-19 Reported Patient Impact and Hospital Capacity by Facility
Epi surveillance:
Health facility
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
Colombia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Malawi COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Australia Household Impacts of Covid-19 Survey November 2020
Survey:
Longitudinal
Canada - British Columbia COVID-19 Situation Report 2020-2022
British Columbia (BC) COVID-19 Situation Report
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Mozambique COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Mali COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Central African Republic COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020
RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020
Epi surveillance:
Subnationally representative
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint
GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
Uganda COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
South Africa COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Individual - Interview
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Rural India COVID-19 Related Shocks Survey 2020 Round 3 (COVIDRS-R3)
COVID-19 Related Shocks in Rural India 2020, Round 3
Survey:
Household - Individual - Interview - Rural only
Mexico - Yucatán Under-5 Endline Household Survey 2020
Survey:
Cross-sectional - Household - Individual - Interview
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Kolkata: One in Four People Have Covid Antibodies
GHDx Entry last modified on: May 12, 2022
Chile COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Subscribe